HEADER TRANSFERASE/TRANSFERASE INHIBITOR 30-OCT-21 7VTO TITLE THE CRYSTAL STRUCTURE OF PAK1 WITH THE INHIBITOR GW8510 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PAK 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ALPHA-PAK,P21-ACTIVATED KINASE 1,PAK-1,P65-PAK; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PAK1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PAK1, INHIBITOR, COMPLEX, TRANSFERASE, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.J.ZHU REVDAT 2 29-NOV-23 7VTO 1 REMARK REVDAT 1 02-NOV-22 7VTO 0 JRNL AUTH S.J.ZHU JRNL TITL THE CRYSTAL STRUCTURE OF PAK1 WITH THE INHIBITOR GW8510 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.59 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.59 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.75 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 20326 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.236 REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.610 REMARK 3 FREE R VALUE TEST SET COUNT : 938 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.7500 - 4.9400 1.00 2815 160 0.2120 0.2283 REMARK 3 2 4.9400 - 3.9200 1.00 2787 144 0.2072 0.2150 REMARK 3 3 3.9200 - 3.4300 1.00 2807 120 0.2322 0.2389 REMARK 3 4 3.4300 - 3.1200 1.00 2759 159 0.2698 0.3335 REMARK 3 5 3.1200 - 2.8900 1.00 2774 106 0.2863 0.3109 REMARK 3 6 2.8900 - 2.7200 1.00 2795 147 0.3182 0.3335 REMARK 3 7 2.7200 - 2.5900 0.95 2651 102 0.3297 0.3493 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.282 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.207 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 65.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 73.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.013 4327 REMARK 3 ANGLE : 1.214 5863 REMARK 3 CHIRALITY : 0.081 673 REMARK 3 PLANARITY : 0.006 740 REMARK 3 DIHEDRAL : 21.944 1620 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7VTO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-NOV-21. REMARK 100 THE DEPOSITION ID IS D_1300025373. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-NOV-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 300K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20326 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.570 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.57 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.66 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 3Q53 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS PH 8.5, 0.2 MGCL2, 24% PEG REMARK 280 3350, 5 MM TCEP, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.90750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 248 REMARK 465 SER A 249 REMARK 465 ASP A 250 REMARK 465 GLU A 251 REMARK 465 GLU A 252 REMARK 465 ILE A 253 REMARK 465 LEU A 254 REMARK 465 GLU A 255 REMARK 465 LYS A 256 REMARK 465 SER A 262 REMARK 465 VAL A 263 REMARK 465 GLY A 264 REMARK 465 ASP A 265 REMARK 465 PRO A 266 REMARK 465 LYS A 267 REMARK 465 LYS A 268 REMARK 465 LYS A 269 REMARK 465 TYR A 270 REMARK 465 THR A 271 REMARK 465 ARG A 272 REMARK 465 PHE A 273 REMARK 465 GLU A 274 REMARK 465 MET A 301 REMARK 465 ASN A 302 REMARK 465 LEU A 303 REMARK 465 GLN A 304 REMARK 465 GLN A 305 REMARK 465 GLN A 306 REMARK 465 LEU A 335 REMARK 465 VAL A 336 REMARK 465 GLY A 337 REMARK 465 ASP A 338 REMARK 465 GLU A 339 REMARK 465 ASN A 543 REMARK 465 ASN A 544 REMARK 465 HIS A 545 REMARK 465 GLY A 546 REMARK 465 ASN A 547 REMARK 465 SER A 548 REMARK 465 GLY B 248 REMARK 465 SER B 249 REMARK 465 ASP B 250 REMARK 465 GLU B 251 REMARK 465 GLU B 252 REMARK 465 ILE B 253 REMARK 465 LEU B 254 REMARK 465 GLY B 409 REMARK 465 PHE B 410 REMARK 465 CYS B 411 REMARK 465 ALA B 412 REMARK 465 GLN B 413 REMARK 465 ILE B 414 REMARK 465 THR B 415 REMARK 465 PRO B 416 REMARK 465 GLU B 417 REMARK 465 GLN B 418 REMARK 465 ASN B 543 REMARK 465 ASN B 544 REMARK 465 HIS B 545 REMARK 465 GLY B 546 REMARK 465 ASN B 547 REMARK 465 SER B 548 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 278 CG CD OE1 NE2 REMARK 470 SER A 281 OG REMARK 470 TYR A 330 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG B 258 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 304 CG CD OE1 NE2 REMARK 470 LYS B 308 CG CD CE NZ REMARK 470 LYS B 309 CG CD CE NZ REMARK 470 ASP B 338 CG OD1 OD2 REMARK 470 TRP B 430 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 430 CZ3 CH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 259 -36.95 -28.92 REMARK 500 ALA A 280 -130.07 47.53 REMARK 500 ARG A 388 -0.29 74.83 REMARK 500 ASP A 407 76.91 64.25 REMARK 500 ARG B 388 -8.22 75.23 REMARK 500 THR B 427 12.18 82.87 REMARK 500 REMARK 500 REMARK: NULL DBREF 7VTO A 249 545 UNP Q13153 PAK1_HUMAN 249 545 DBREF 7VTO B 249 545 UNP Q13153 PAK1_HUMAN 249 545 SEQADV 7VTO GLY A 248 UNP Q13153 EXPRESSION TAG SEQADV 7VTO ASN A 389 UNP Q13153 ASP 389 CONFLICT SEQADV 7VTO GLY A 546 UNP Q13153 EXPRESSION TAG SEQADV 7VTO ASN A 547 UNP Q13153 EXPRESSION TAG SEQADV 7VTO SER A 548 UNP Q13153 EXPRESSION TAG SEQADV 7VTO GLY B 248 UNP Q13153 EXPRESSION TAG SEQADV 7VTO ASN B 389 UNP Q13153 ASP 389 CONFLICT SEQADV 7VTO GLY B 546 UNP Q13153 EXPRESSION TAG SEQADV 7VTO ASN B 547 UNP Q13153 EXPRESSION TAG SEQADV 7VTO SER B 548 UNP Q13153 EXPRESSION TAG SEQRES 1 A 301 GLY SER ASP GLU GLU ILE LEU GLU LYS LEU ARG SER ILE SEQRES 2 A 301 VAL SER VAL GLY ASP PRO LYS LYS LYS TYR THR ARG PHE SEQRES 3 A 301 GLU LYS ILE GLY GLN GLY ALA SER GLY THR VAL TYR THR SEQRES 4 A 301 ALA MET ASP VAL ALA THR GLY GLN GLU VAL ALA ILE LYS SEQRES 5 A 301 GLN MET ASN LEU GLN GLN GLN PRO LYS LYS GLU LEU ILE SEQRES 6 A 301 ILE ASN GLU ILE LEU VAL MET ARG GLU ASN LYS ASN PRO SEQRES 7 A 301 ASN ILE VAL ASN TYR LEU ASP SER TYR LEU VAL GLY ASP SEQRES 8 A 301 GLU LEU TRP VAL VAL MET GLU TYR LEU ALA GLY GLY SER SEQRES 9 A 301 LEU THR ASP VAL VAL THR GLU THR CYS MET ASP GLU GLY SEQRES 10 A 301 GLN ILE ALA ALA VAL CYS ARG GLU CYS LEU GLN ALA LEU SEQRES 11 A 301 GLU PHE LEU HIS SER ASN GLN VAL ILE HIS ARG ASN ILE SEQRES 12 A 301 LYS SER ASP ASN ILE LEU LEU GLY MET ASP GLY SER VAL SEQRES 13 A 301 LYS LEU THR ASP PHE GLY PHE CYS ALA GLN ILE THR PRO SEQRES 14 A 301 GLU GLN SER LYS ARG SER TPO MET VAL GLY THR PRO TYR SEQRES 15 A 301 TRP MET ALA PRO GLU VAL VAL THR ARG LYS ALA TYR GLY SEQRES 16 A 301 PRO LYS VAL ASP ILE TRP SER LEU GLY ILE MET ALA ILE SEQRES 17 A 301 GLU MET ILE GLU GLY GLU PRO PRO TYR LEU ASN GLU ASN SEQRES 18 A 301 PRO LEU ARG ALA LEU TYR LEU ILE ALA THR ASN GLY THR SEQRES 19 A 301 PRO GLU LEU GLN ASN PRO GLU LYS LEU SER ALA ILE PHE SEQRES 20 A 301 ARG ASP PHE LEU ASN ARG CYS LEU GLU MET ASP VAL GLU SEQRES 21 A 301 LYS ARG GLY SER ALA LYS GLU LEU LEU GLN HIS GLN PHE SEQRES 22 A 301 LEU LYS ILE ALA LYS PRO LEU SER SER LEU THR PRO LEU SEQRES 23 A 301 ILE ALA ALA ALA LYS GLU ALA THR LYS ASN ASN HIS GLY SEQRES 24 A 301 ASN SER SEQRES 1 B 301 GLY SER ASP GLU GLU ILE LEU GLU LYS LEU ARG SER ILE SEQRES 2 B 301 VAL SER VAL GLY ASP PRO LYS LYS LYS TYR THR ARG PHE SEQRES 3 B 301 GLU LYS ILE GLY GLN GLY ALA SER GLY THR VAL TYR THR SEQRES 4 B 301 ALA MET ASP VAL ALA THR GLY GLN GLU VAL ALA ILE LYS SEQRES 5 B 301 GLN MET ASN LEU GLN GLN GLN PRO LYS LYS GLU LEU ILE SEQRES 6 B 301 ILE ASN GLU ILE LEU VAL MET ARG GLU ASN LYS ASN PRO SEQRES 7 B 301 ASN ILE VAL ASN TYR LEU ASP SER TYR LEU VAL GLY ASP SEQRES 8 B 301 GLU LEU TRP VAL VAL MET GLU TYR LEU ALA GLY GLY SER SEQRES 9 B 301 LEU THR ASP VAL VAL THR GLU THR CYS MET ASP GLU GLY SEQRES 10 B 301 GLN ILE ALA ALA VAL CYS ARG GLU CYS LEU GLN ALA LEU SEQRES 11 B 301 GLU PHE LEU HIS SER ASN GLN VAL ILE HIS ARG ASN ILE SEQRES 12 B 301 LYS SER ASP ASN ILE LEU LEU GLY MET ASP GLY SER VAL SEQRES 13 B 301 LYS LEU THR ASP PHE GLY PHE CYS ALA GLN ILE THR PRO SEQRES 14 B 301 GLU GLN SER LYS ARG SER TPO MET VAL GLY THR PRO TYR SEQRES 15 B 301 TRP MET ALA PRO GLU VAL VAL THR ARG LYS ALA TYR GLY SEQRES 16 B 301 PRO LYS VAL ASP ILE TRP SER LEU GLY ILE MET ALA ILE SEQRES 17 B 301 GLU MET ILE GLU GLY GLU PRO PRO TYR LEU ASN GLU ASN SEQRES 18 B 301 PRO LEU ARG ALA LEU TYR LEU ILE ALA THR ASN GLY THR SEQRES 19 B 301 PRO GLU LEU GLN ASN PRO GLU LYS LEU SER ALA ILE PHE SEQRES 20 B 301 ARG ASP PHE LEU ASN ARG CYS LEU GLU MET ASP VAL GLU SEQRES 21 B 301 LYS ARG GLY SER ALA LYS GLU LEU LEU GLN HIS GLN PHE SEQRES 22 B 301 LEU LYS ILE ALA LYS PRO LEU SER SER LEU THR PRO LEU SEQRES 23 B 301 ILE ALA ALA ALA LYS GLU ALA THR LYS ASN ASN HIS GLY SEQRES 24 B 301 ASN SER MODRES 7VTO TPO A 423 THR MODIFIED RESIDUE MODRES 7VTO TPO B 423 THR MODIFIED RESIDUE HET TPO A 423 11 HET TPO B 423 11 HET 107 A 601 31 HET 107 B 601 31 HETNAM TPO PHOSPHOTHREONINE HETNAM 107 4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N- HETNAM 2 107 PYRIDIN-2-YL-BENZENESULFONAMIDE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 3 107 2(C21 H15 N5 O3 S2) FORMUL 5 HOH *10(H2 O) HELIX 1 AA1 LYS A 308 GLU A 321 1 14 HELIX 2 AA2 SER A 351 THR A 359 1 9 HELIX 3 AA3 ASP A 362 ASN A 383 1 22 HELIX 4 AA4 LYS A 391 ASP A 393 5 3 HELIX 5 AA5 THR A 427 MET A 431 5 5 HELIX 6 AA6 ALA A 432 THR A 437 1 6 HELIX 7 AA7 PRO A 443 GLY A 460 1 18 HELIX 8 AA8 ASN A 468 GLY A 480 1 13 HELIX 9 AA9 ASN A 486 LEU A 490 5 5 HELIX 10 AB1 SER A 491 LEU A 502 1 12 HELIX 11 AB2 SER A 511 LEU A 516 1 6 HELIX 12 AB3 GLN A 517 ALA A 524 5 8 HELIX 13 AB4 PRO A 526 SER A 529 5 4 HELIX 14 AB5 LEU A 530 LYS A 542 1 13 HELIX 15 AB6 LYS B 256 VAL B 261 1 6 HELIX 16 AB7 ASP B 265 LYS B 269 1 5 HELIX 17 AB8 LYS B 309 ASN B 322 1 14 HELIX 18 AB9 SER B 351 THR B 359 1 9 HELIX 19 AC1 ASP B 362 ASN B 383 1 22 HELIX 20 AC2 LYS B 391 ASP B 393 5 3 HELIX 21 AC3 THR B 427 MET B 431 5 5 HELIX 22 AC4 ALA B 432 THR B 437 1 6 HELIX 23 AC5 PRO B 443 GLY B 460 1 18 HELIX 24 AC6 ASN B 468 GLY B 480 1 13 HELIX 25 AC7 ASN B 486 LEU B 490 5 5 HELIX 26 AC8 SER B 491 LEU B 502 1 12 HELIX 27 AC9 SER B 511 LEU B 516 1 6 HELIX 28 AD1 GLN B 517 HIS B 518 5 2 HELIX 29 AD2 GLN B 519 ALA B 524 5 6 HELIX 30 AD3 PRO B 526 SER B 529 5 4 HELIX 31 AD4 LEU B 530 THR B 541 1 12 SHEET 1 AA1 4 VAL A 284 MET A 288 0 SHEET 2 AA1 4 GLU A 295 LYS A 299 -1 O VAL A 296 N ALA A 287 SHEET 3 AA1 4 VAL A 342 GLU A 345 -1 O MET A 344 N ALA A 297 SHEET 4 AA1 4 TYR A 330 SER A 333 -1 N ASP A 332 O VAL A 343 SHEET 1 AA2 2 VAL A 385 ILE A 386 0 SHEET 2 AA2 2 ALA A 412 GLN A 413 -1 O ALA A 412 N ILE A 386 SHEET 1 AA3 2 ILE A 395 LEU A 397 0 SHEET 2 AA3 2 VAL A 403 LEU A 405 -1 O LYS A 404 N LEU A 396 SHEET 1 AA4 5 TYR B 270 GLY B 277 0 SHEET 2 AA4 5 THR B 283 ASP B 289 -1 O THR B 286 N GLU B 274 SHEET 3 AA4 5 GLU B 295 MET B 301 -1 O ILE B 298 N TYR B 285 SHEET 4 AA4 5 GLU B 339 GLU B 345 -1 O LEU B 340 N MET B 301 SHEET 5 AA4 5 TYR B 330 VAL B 336 -1 N LEU B 331 O VAL B 343 SHEET 1 AA5 2 ILE B 395 LEU B 397 0 SHEET 2 AA5 2 VAL B 403 LEU B 405 -1 O LYS B 404 N LEU B 396 SSBOND 1 CYS A 360 CYS B 360 1555 1556 2.37 LINK C SER A 422 N TPO A 423 1555 1555 1.32 LINK C TPO A 423 N MET A 424 1555 1555 1.32 LINK C SER B 422 N TPO B 423 1555 1555 1.32 LINK C TPO B 423 N MET B 424 1555 1555 1.33 CRYST1 63.531 81.815 66.269 90.00 106.07 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015740 0.000000 0.004533 0.00000 SCALE2 0.000000 0.012223 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015703 0.00000